Scleral lenses, a marvel of modern optometry, hold a fascinating chapter in the history of vision correction. Today, they stand as a testament to human ingenuity and the relentless pursuit of [...]
We have exciting news for patients at Compton Eye Associates: the FDA has recently approved MYDCOMBI™, a novel ophthalmic spray developed by Eyenovia, Inc. This approval marks a significant [...]
Myopia, or nearsightedness, is a prevalent and concerning condition among children. The treatment landscape has evolved over the years, with atropine eye drops emerging as a prominent option. [...]
As we step into the summer of 2023, a groundbreaking advancement in eye care has made its way to the U.S.: Bausch + Lomb’s INFUSE Multifocal SiHy Contacts. At Compton Eye Associates, [...]